Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16388526.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Therapeutic decisions in recurrent oral and oropharyngeal squamous carcinoma (SCC) remain controversial. Two hundred forty-six consecutive patients who underwent salvage surgery for recurrent squamous cell carcinoma (SCC) of the oral cavity and oropharynx were studied. The tumor sites were lip, 33 cases; oral cavity, 143; oropharynx, 70. The previous treatment was surgery in 73 patients, radiotherapy in 96, combined surgery and radiotherapy in 76, and chemotherapy in one. The clinical stage of recurrence was I/II in 51 cases and III/IV in 195 cases. The disease-free interval (DFI) was less than 1 year in 156 cases and greater than 1 year in 90 cases. The rate of recurrence was 54.9%, and the overall 5-year actuarial survival rate was 32.3%. The significant prognostic factors in multivariate analysis were restage (p = .049) and DFI (p = .045). Patients with recurrent oral and oropharyngeal SCC at initial clinical stages (rCS I and II) and with a DFI greater than 1 year had a favorable prognosis.
Medical subject headings
- Carcinoma, Squamous Cell
- Mouth Neoplasms
- Neoplasm Recurrence, Local
- Oropharyngeal Neoplasms
- Salvage Therapy